Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-02-10 @ 11:52 AM
Study NCT ID:
NCT03458650
Status:
COMPLETED
Last Update Posted:
2018-05-30
First Post:
2018-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.
Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-25
First Submit QC Date:
None
Study First Post Date:
2018-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-28
Last Update Post Date:
2018-05-30
Last Update Post Date Type:
ACTUAL